- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00056394
Coping Skills Training for Early Rheumatoid Arthritis
Study Overview
Status
Conditions
Detailed Description
RA is a serious and complex disease that taxes patients' coping resources. Patients with RA must cope with pain and with major life stresses, including disruptions in their health, work, family, and marital functioning.
Recognition of the morbidity and mortality associated with RA has increased interest in early interventions. Rapid disease progression during the first few years of RA taxes patients' coping efforts. Those who cope well with the early stages of RA can maintain an active and rewarding lifestyle. Those who do not may become depressed, decrease physical activity, and develop a sedentary, restricted lifestyle that contributes to long-term disability and overdependence on family and friends.
This study will evaluate the effectiveness of early coping skills training (CST) to enhance self-efficacy, prepare patients to cope with future pain, and prevent the development of behaviors that may increase long-term psychological distress and physical disability. The comprehensive CST intervention combines traditional CST with CST components tailored to rheumatoid arthritis patients. It is designed to teach traditional coping skills such as attention diversion, cognitive restructuring, and changes in activity to control and decrease pain.
Participants will be randomized to one of three study groups: 1) comprehensive pain coping skills training; 2) arthritis education; or 3) standard care. Study participants assigned to the comprehensive CST and the arthritis education groups will be asked to attend ten weekly, 80-minute treatment sessions. These ten sessions will be followed by a series of six biweekly follow-up telephone calls.
Study participants in the arthritis education group will learn about the nature and treatment of rheumatoid arthritis as well as the benefits of exercise and joint protection. Study participants in the standard care group will continue to receive care from their rheumatologists but will not participate in any treatment sessions.
Measures of pain, disability, pain coping, and self efficacy will be collected during evaluation sessions before and after the treatment phase. Participants attend 5 evaluation sessions and will be followed for 18 months.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
Durham, North Carolina, United States, 27705
- Duke University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Meet at least 4 of the 7 criteria for RA classification based on the 1987 American College of Rheumatology criteria
- Onset of RA symptoms within 2 years of study entry
Exclusion Criteria
- Known organic disease that significantly affects function
- Rheumatic disorders in addition to RA that significantly affect function
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
Participants will receive comprehensive pain coping skills.
|
10 weekly, 80-minute coping skills treatment sessions, followed by a series of six biweekly follow-up telephone calls.
|
|
Active Comparator: 2
Participants will receive arthritis education.
|
10 weekly, 80-minute treatment sessions, followed by a series of six biweekly follow-up telephone calls.
Participants will learn about the nature and treatment of rheumatoid arthritis as well as the benefits of exercise and joint protection.
|
|
Active Comparator: 3
Participants will receive standard care.
|
Usual care from participants' rheumatologists but no treatment sessions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pain
Time Frame: Measured at Week 10
|
Measured at Week 10
|
|
Psychological disability
Time Frame: Measured at Week 10
|
Measured at Week 10
|
|
Physical disability
Time Frame: Measured at Week 10
|
Measured at Week 10
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Erythrocyte sedimentation rate
Time Frame: Measured at Week 10
|
Measured at Week 10
|
|
Joint tenderness count
Time Frame: Measured at Week 10
|
Measured at Week 10
|
|
Grip strength
Time Frame: Measured at Week 10
|
Measured at Week 10
|
|
Physician assessment of disease activity
Time Frame: Measured at Week 10
|
Measured at Week 10
|
|
C reactive protein
Time Frame: Measured at Week 10
|
Measured at Week 10
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Francis J. Keefe, PhD, Duke University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00007830
- R01AR047218 (U.S. NIH Grant/Contract)
- NIAMS-086
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.